Daniel Franco

687 total citations
24 papers, 510 citations indexed

About

Daniel Franco is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Daniel Franco has authored 24 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in Daniel Franco's work include Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Alzheimer's disease research and treatments (4 papers) and Pancreatitis Pathology and Treatment (3 papers). Daniel Franco is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Alzheimer's disease research and treatments (4 papers) and Pancreatitis Pathology and Treatment (3 papers). Daniel Franco collaborates with scholars based in United States, United Kingdom and Colombia. Daniel Franco's co-authors include Seth Truran, Raymond Q. Migrino, Sanjay Gupta, Eswar Shankar, Peter D. Reaven, Eric A. Schwartz, Ailin Zhang, David A. D’Alessio, Parameswaran Hari and Juraj Koška and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Molecular and Cellular Biology.

In The Last Decade

Daniel Franco

23 papers receiving 506 citations

Peers

Daniel Franco
Seth Truran United States
Melroy Miranda Switzerland
Hu Xu China
Mary Y. K. Lee Hong Kong
Li‐Hao Huang United States
Bong Jun Cho South Korea
Seth Truran United States
Daniel Franco
Citations per year, relative to Daniel Franco Daniel Franco (= 1×) peers Seth Truran

Countries citing papers authored by Daniel Franco

Since Specialization
Citations

This map shows the geographic impact of Daniel Franco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Franco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Franco more than expected).

Fields of papers citing papers by Daniel Franco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Franco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Franco. The network helps show where Daniel Franco may publish in the future.

Co-authorship network of co-authors of Daniel Franco

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Franco. A scholar is included among the top collaborators of Daniel Franco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Franco. Daniel Franco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shankar, Eswar, et al.. (2020). Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer. Toxicology and Applied Pharmacology. 404. 115200–115200. 21 indexed citations
3.
Shankar, Eswar, et al.. (2020). Novel approach to therapeutic targeting of castration-resistant prostate cancer. Medical Hypotheses. 140. 109639–109639. 7 indexed citations
4.
Truran, Seth, Geidy E. Serrano, Thomas G. Beach, et al.. (2020). Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside‐Containing Nanoliposomes. Journal of the American Heart Association. 9(2). e014810–e014810. 20 indexed citations
5.
Kanwal, Rajnee, Stephen Moreton, Daniel Franco, & Sanjay Gupta. (2018). Abstract 251: Luteolin-mediated increase in miR-26a inhibits prostate cancer cell growth and induces cell cycle arrest targeting EZH2. Cancer Research. 78(13_Supplement). 251–251. 2 indexed citations
6.
Migrino, Raymond Q., Hannah A. Davies, Seth Truran, et al.. (2017). Amyloidogenic Medin Induces Endothelial Dysfunction and Vascular Inflammation Through the Receptor for Advanced Glycation Endproducts. The FASEB Journal. 31(S1). 1 indexed citations
7.
Franco, Daniel, et al.. (2016). HDL inhibits saturated fatty acid mediated augmentation of innate immune responses in endothelial cells by a novel pathway. Atherosclerosis. 259. 83–96. 16 indexed citations
8.
Franco, Daniel, Seth Truran, Volkmar Weissig, et al.. (2016). Monosialoganglioside‐Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins. Journal of the American Heart Association. 5(6). 13 indexed citations
9.
Davies, Hannah A., Marie M. Phelan, Mark C. Wilkinson, et al.. (2015). Oxidative Stress Alters the Morphology and Toxicity of Aortic Medial Amyloid. Biophysical Journal. 109(11). 2363–2370. 18 indexed citations
10.
Truran, Seth, Geidy E. Serrano, Daniel Franco, et al.. (2015). Abstract 18245: Palmitic Acid-induced Endothelial Dysfunction in Human Leptomeningeal and Adipose Arterioles. Circulation. 132(suppl_3). 1 indexed citations
11.
Koška, Juraj, Michelle Sands, James Liu, et al.. (2015). Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans. Diabetes. 64(7). 2624–2635. 143 indexed citations
12.
Truran, Seth, Volkmar Weissig, Jillian Madine, et al.. (2015). Nanoliposomes protect against human arteriole endothelial dysfunction induced by β-amyloid peptide. Journal of Cerebral Blood Flow & Metabolism. 36(2). 405–412. 11 indexed citations
14.
Truran, Seth, Daniel Franco, Alex E. Roher, et al.. (2014). Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy. Journal of Neuroscience Methods. 235. 123–129. 13 indexed citations
15.
Truran, Seth, Volkmar Weissig, Marina Ramı́rez-Alvarado, et al.. (2013). Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury. Journal of Liposome Research. 24(1). 69–73. 14 indexed citations
16.
Franco, Daniel, Seth Truran, David D. Gutterman, et al.. (2012). Protective role of clusterin in preserving endothelial function in AL amyloidosis. Atherosclerosis. 225(1). 220–223. 18 indexed citations
17.
Migrino, Raymond Q., Seth Truran, David D. Gutterman, et al.. (2011). Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. American Journal of Physiology-Heart and Circulatory Physiology. 301(6). H2305–H2312. 57 indexed citations
18.
Franco, Daniel & Yung Chang. (2009). Accessibility of chromosomal recombination breaks in nuclei of wild-type and DNA-PKcs-deficient cells. DNA repair. 8(7). 813–821. 3 indexed citations
19.
Franco, Daniel, et al.. (2000). Activation of V(D)J Recombination Induces the Formation of Interlocus Joints and Hybrid Joints in scid Pre-B-Cell Lines. Molecular and Cellular Biology. 20(19). 7170–7177. 7 indexed citations
20.
Borgonovo, Giacomo, et al.. (1996). Carcinosarcoma of the liver with mesenchymal differentiation: a case report.. PubMed. 43(7). 255–9. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026